Antitrust Antitrust

Comment: Vifor Pharma disparagement case sees EU antitrust regulator break new ground

By Nicholas Hirst
  • 21 Jun 2022 11:54
  • 21 Jun 2022 11:54
With its new probe against Vifor Pharma, the EU's antitrust enforcer is heading into new territory: The concern that a dominant company may have abused its market power merely by spreading negative information about a rival.  

But if the theory of harm is newish, at least for the

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News